Biotech & pharma
Novo Nordisk signs up to $2.1 billion deal with Vivtex to develop oral obesity therapies
By Cygnus | 25 Feb 2026
Novo Nordisk signed a partnership worth up to $2.1 billion with Vivtex to develop oral treatments for obesity and diabetes.
Indian Patent Office rejects AbbVie patent bid for cancer drug Venetoclax; generics may enter market
By Cygnus | 23 Jan 2026
The Indian Patent Office rejected AbbVie’s patent application for cancer drug Venetoclax (Venclexta), a decision expected to ease the entry of lower-cost generics.
Sun Pharma Weighs $10 Billion Takeover of Organon to Expand US Footprint
By Cygnus | 19 Jan 2026
Sun Pharma is evaluating a ~$10B acquisition of Organon to expand its U.S. footprint in women's health and biosimilars, according to reports.
The $280 Ozempic: How a Canadian Bridge to India is Slashing U.S. Weight-Loss Costs
By Axel Miller | 07 Jan 2026
U.S. patients are bypassing $1,100 retail prices with $280 India-sourced Ozempic pens via Canada. A deep dive into the 2026 semaglutide supply chain.
Glenmark Pharma Hits Record High on Landmark AbbVie Licensing Deal
By Cygnus | 11 Jul 2025
Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a significant licensing agreement with U.S. drugmaker AbbVie.
India achieves breakthrough in gene therapy for Haemophilia
25 Apr 2025
Bengaluru’s BRIC-inStem institute has achieved a breakthrough in gene therapy for Haemophilia, union minister for science and technology, Dr Jitendra Singh said
Bayer seeks legal cover in US for its Roundup weedkiller sales
08 Mar 2025
German pharmaceutical and biotechnology group, Bayer, has told the US government that it would have to stop selling its Roundup weedkiller in the United States
Balrampur Chini sets up India's first biopolymer manufacturing unit in Uttar Pradesh
24 Feb 2025
Balrampur Chini Mills Ltd (BCML), one of the largest sugar mills in the country, is diversifying further by venturing into the production of Poly Lactic Acid (PLA)
Scientists at Mohali’s Nano Science Institute identify common biomarker for cancer detection
21 Feb 2025
A research team at the Institute of Nano Science and Technology (INST), Mohali has identified a common biomarker for early detection of a range of cancers
.webp)
PM Modi hails Genome project as data of 10,000 Indians go live
09 Jan 2025
Prime Minister Narendra Modi on Thursday announced the completion of the Genome India project, which makes available database of 10,000 Indians
Pune’s Agarkar Institute develops novel molecule for treating Alzheimer’s disease
26 Oct 2024
Scientists from Agharkar Research Institute, Pune, an autonomous institute of Department of Science and Technology,
Victor Ambros and Gary Ruvkun of US win Medicine Nobel for discovery of microRNA
08 Oct 2024
Victor Ambros, a professor at the Harvard Medical School and Gary Ruvkun, an investigator with Massachusetts General Hospital, jointly won the 2024 Nobel Prize in Physiology or Medicine.
Western drugmakers pivot to India as tensions with China prompt supply chain shifts
27 Nov 2023
In a strategic move to reduce dependence on Chinese contractors in drug production, global pharmaceutical companies are turning to Indian manufacturers.
British Airways joins Project Speedbird for cleaner aviation fuel
17 Nov 2023
The project is supported by the British government with a £9 million grant from the Advanced Fuels Fund (AFF).
Merck and Daiichi partner on a $5.5 billion deal for cancer therapy development
20 Oct 2023
The American pharmaceutical company Merck will start a joint venture with Daiichi Sankyo to develop three of its candidate cancer drugs.
U.S. pharmacy store Rite Aid files for bankruptcy protection amid several lawsuits
16 Oct 2023
Rite Aid filed for Chapter 11 bankruptcy on Sunday, October 15, 2023, taking a step to suspend the lawsuits against the drugstore chain related to its alleged
CRISIL predicts an 8-10% revenue growth for Indian pharma industry in current fiscal year
11 Sep 2023
According to a report, the Indian pharmaceutical industry is expected to achieve 8 to 10 per cent revenue growth in the current fiscal year.
Accusations from Iowa farmers: China allegedly stealing American seeds
08 Aug 2023
Farmers in Iowa are making accusations against the Chinese state, alleging the theft of invaluable seed samples from America.
US scientists create 'living robots' that can reproduce themselves
01 Dec 2021
With the help of artificial intelligence, the researchers have found that the Xenobots are able to find tiny stem cells in a petri dish, gather hundreds of them inside their mouth, and bundle them out as new Xenobots in a few days
Latest articles
Featured articles
The great memory squeeze: Why your next RAM upgrade could cost more
By Axel Miller | 02 Mar 2026
Rising AI infrastructure demand is tightening global memory supply, driving higher RAM prices for PCs and smartphones and reshaping the semiconductor cycle.
The agentic shift: re-architecting business for the 2026 autonomy cycle
By Cygnus | 26 Feb 2026
From chip competition to IT pricing models, the rise of agentic AI is transforming how companies build, deploy, and monetize technology.
The mainframe moment: how AI-driven modernization is reshaping the COBOL economy
By Axel Miller | 24 Feb 2026
New AI coding tools are accelerating legacy system modernization, raising opportunities and risks for banks, enterprises, and the IT services industry.
The concrete cloud: India’s $250 billion bet on the physical foundations of AI
By Cygnus | 23 Feb 2026
India pivots to AI's physical layer with $250B in pledges for chips and data centers to lead the new era of 'Agentic Commerce.' Read the full report.
The $250 billion pivot: how 2026 became the year AI paid the rent
By Cygnus | 18 Feb 2026
2026 marks the shift from AI “promise” to “profitability.” Explore how India’s sovereign compute and Infosys’s revenue metrics are defining a $250B market pivot.
The analog antidote: perception, reality, and the "Windows crisis" narrative
By Cygnus | 17 Feb 2026
Viral claims of a Windows collapse contrast with market data showing a slower shift as enterprises weigh AI, hardware costs, and legacy systems.
The analog antidote: why Americans are trading algorithms for physical media
By Cygnus | 16 Feb 2026
Vinyl, books, and DVDs are seeing renewed interest as Americans seek ownership, focus, and a break from screen fatigue in an increasingly digital world.
China opens market to 53 African nations in zero-tariff pivot
By Cygnus | 16 Feb 2026
China will grant zero-tariff access to 53 African nations from May 2026, reshaping global trade ties and deepening economic links across the Global South.
The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy
By Cygnus | 13 Feb 2026
The Trump EPA moves to rescind the 2009 Endangerment Finding, reshaping federal climate authority and business risk.
